Bold Therapeutics

Vancouver, Canada · Founded 2018 · Privately Held (backing)

Developer of novel metallotherapeutics metal-based small molecules designed for the treatment of cancer. Bold Therapeutics is based in Vancouver, Canada and was founded in 2018. Its last known valuation is $140 million. It has raised $25 million across 1 recorded round; the latest was a $5.5 million early-stage round in Jul 2018.

Last price · $/share
—
Implied valuation
$140.0M
Total raised
$25.0M
Last round
Early Stage VC
Jul 2018

Who backs Bold Therapeutics?

4 investors
InvestorType
Life Sciences BCOther
Gaston Capital—
National Research Council Canada—
Tampa Bay Technology Incubator—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Bold Therapeutics investors

4 investors are on record for Bold Therapeutics, including Life Sciences BC, Gaston Capital, National Research Council Canada and Tampa Bay Technology Incubator. The early-stage round in Jul 2018 drew 48 investors.

Free account
More of Bold Therapeutics with a free account
  • ·Watch Bold Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Bold Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View